Coherus Oncology (CHRS) Capital Expenditures (2013 - 2025)
Coherus Oncology's Capital Expenditures was $8.38 million in Q4 2025.
Powered by 
Analysis
Coherus Oncology (CHRS) Capital Expenditures (2013 - 2025) Analysis & Trends
For FY2025, Capital Expenditures at Coherus Oncology came in at -$470.31 million.
- In earlier years, Capital Expenditures was -$227.82 million in FY2024, $286,000 in FY2023 (-86.0%), $2.04 million in FY2022 (+58.2%) and $1.29 million in FY2021 (-82.2%).
- The Q4 2025 figure marks the highest quarterly Capital Expenditures in data going back to Q4 2013.
- The best year-over-year quarter for Capital Expenditures over five years was Q1 2022 (growth of 324.1%); the worst was Q1 2021 (a decline of 91.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 8.38 Mn |
| Jun 30, 2025 | -483.40 Mn |
| Mar 31, 2025 | 4.72 Mn |
| Jun 30, 2024 | -40.00 Mn |
| Mar 31, 2024 | -187.82 Mn |
| Dec 31, 2023 | 34,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 152,000.00 |
| Dec 31, 2022 | 87,000.00 |
| Sep 30, 2022 | 457,000.00 |
| Jun 30, 2022 | 880,000.00 |
| Mar 31, 2022 | 615,000.00 |
| Dec 31, 2021 | 468,000.00 |
| Sep 30, 2021 | 261,000.00 |
| Jun 30, 2021 | 415,000.00 |
| Mar 31, 2021 | 145,000.00 |
| Dec 31, 2020 | 952,000.00 |
| Sep 30, 2020 | 2.11 Mn |
| Jun 30, 2020 | 2.38 Mn |
| Mar 31, 2020 | 1.78 Mn |
API Access
Coherus Oncology Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();